[A randomized clinical study of preoperative chemotherapy for esophageal carcinoma].
To evaluate the effect of preoperative chemotherapy on the prognosis of stage II or III patients with esophageal carcinoma. From February 1991 to June 1994, 50 patients with stage II, III esophageal carcinoma were treated with preoperative combination (CDDP) chemotherapy and compared with 50 patients received operation alone. The 5-year survival rate of the operation group and preoperative chemotherapy group was 32% and 46%, respectively. The difference was statistically significant. Preoperative chemotherapy improves survival of surgically treated esophageal cancer patients.